"Proprietary Name","NDC Package Code","Strength","Dosage Form","Route","Appl. No.","Labeler Name","Product NDC","Nonproprietary Name","Substance Name","Product Type Name","Start Marketing Date","End Marketing Date","Market Category","Package Description","Pharm Class","DEA","Sample Package","Listing Record Certified Through:"
"guanfacine","0228-2850-11","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200881","Actavis Pharma, Inc.","0228-2850","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2014","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2850-11)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"guanfacine","0228-2851-11","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200881","Actavis Pharma, Inc.","0228-2851","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2014","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2851-11)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"guanfacine","0228-2853-11","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200881","Actavis Pharma, Inc.","0228-2853","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2014","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2853-11)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"guanfacine","0228-2855-11","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200881","Actavis Pharma, Inc.","0228-2855","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2014","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2855-11)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","0591-0444-01","1 mg/1","TABLET","ORAL","ANDA074145","Actavis Pharma, Inc.","0591-0444","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/17/1995","N/A","ANDA","100 TABLET in 1 BOTTLE, PLASTIC (0591-0444-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","0591-0453-01","2 mg/1","TABLET","ORAL","ANDA074145","Actavis Pharma, Inc.","0591-0453","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/17/1995","N/A","ANDA","100 TABLET in 1 BOTTLE (0591-0453-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","0904-7140-04","1 mg/1","TABLET","ORAL","ANDA074673","Major Pharmaceuticals","0904-7140","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/02/2013","N/A","ANDA","30 BLISTER PACK in 1 CARTON (0904-7140-04)  / 1 TABLET in 1 BLISTER PACK","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","16714-190-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","NORTHSTAR RXLLC","16714-190","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/17/2021","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-190-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","16714-191-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","NORTHSTAR RXLLC","16714-191","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/17/2021","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-191-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","16714-192-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","NORTHSTAR RXLLC","16714-192","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/17/2021","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-192-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","16714-193-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","NORTHSTAR RXLLC","16714-193","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/17/2021","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-193-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24658-730-01","1 mg/1","TABLET","ORAL","ANDA074673","PuraCap Laboratories LLC dba Blu Pharmaceuticals","24658-730","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/14/2016","N/A","ANDA","100 TABLET in 1 BOTTLE (24658-730-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-533-00","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-533","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/01/2024","N/A","ANDA","100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-533-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-533-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-533","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-533-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-533-10","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-533","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-533-10)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-534-10","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-534","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-534-10)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-534-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-534","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-534-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-534-00","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-534","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/01/2024","N/A","ANDA","100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-534-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-536-10","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-536","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-536-10)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-536-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-536","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-536-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-536-00","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-536","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/01/2024","N/A","ANDA","100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-536-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-538-10","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-538","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-10)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-538-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-538","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","24979-538-00","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Upsher-Smith Laboratories, LLC","24979-538","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/01/2024","N/A","ANDA","100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-538-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","27241-242-01","1 mg/1","TABLET","ORAL","ANDA217293","Ajanta Pharma USA Inc.","27241-242","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/27/2023","N/A","ANDA","100 TABLET in 1 BOTTLE (27241-242-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine","27241-243-01","2 mg/1","TABLET","ORAL","ANDA217293","Ajanta Pharma USA Inc.","27241-243","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/27/2023","N/A","ANDA","100 TABLET in 1 BOTTLE (27241-243-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine","29300-460-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219033","Unichem Pharmaceuticals (USA), Inc.","29300-460","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-460-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","29300-461-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219033","Unichem Pharmaceuticals (USA), Inc.","29300-461","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-461-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","29300-462-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219033","Unichem Pharmaceuticals (USA), Inc.","29300-462","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-462-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","29300-463-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219033","Unichem Pharmaceuticals (USA), Inc.","29300-463","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-463-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"guanfacine","42291-324-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200881","AvKARE","42291-324","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2015","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-324-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"guanfacine","42291-325-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200881","AvKARE","42291-325","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2015","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-325-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"guanfacine","42291-326-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200881","AvKARE","42291-326","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2015","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-326-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"guanfacine","42291-327-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200881","AvKARE","42291-327","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2015","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-327-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","42806-048-01","1 mg/1","TABLET","ORAL","ANDA074673","Epic Pharma, LLC","42806-048","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/02/2013","N/A","ANDA","100 TABLET in 1 BOTTLE (42806-048-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","42806-296-01","2 mg/1","TABLET","ORAL","ANDA074673","Epic Pharma, LLC","42806-296","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/30/2019","N/A","ANDA","100 TABLET in 1 BOTTLE (42806-296-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","46708-745-31","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Limited","46708-745","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-745-31)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","46708-745-91","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Limited","46708-745","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-745-91)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","46708-746-31","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Limited","46708-746","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-746-31)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","46708-746-91","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Limited","46708-746","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-746-91)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","46708-747-31","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Limited","46708-747","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-747-31)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","46708-747-91","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Limited","46708-747","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-747-91)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","46708-748-31","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Limited","46708-748","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-748-31)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","46708-748-91","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Limited","46708-748","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-748-91)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","50090-7129-0","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA213428","A-S Medication Solutions","50090-7129","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/11/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7129-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","50090-7644-0","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","A-S Medication Solutions","50090-7644","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/28/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7644-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","51407-952-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Golden State Medical Supply, Inc.","51407-952","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2026","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-952-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"GUANFACINE","51407-953-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Golden State Medical Supply, Inc.","51407-953","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2026","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-953-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"GUANFACINE","51407-954-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Golden State Medical Supply, Inc.","51407-954","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2026","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-954-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"GUANFACINE","51407-955-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Golden State Medical Supply, Inc.","51407-955","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2026","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-955-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"GUANFACINE","59651-840-01","1 mg/1","TABLET","ORAL","ANDA074796","Aurobindo Pharma Limited","59651-840","GUANFACINE HYDROCHLORIDE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/07/2023","N/A","ANDA","100 TABLET in 1 BOTTLE (59651-840-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","59651-841-01","2 mg/1","TABLET","ORAL","ANDA074796","Aurobindo Pharma Limited","59651-841","GUANFACINE HYDROCHLORIDE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/07/2023","N/A","ANDA","100 TABLET in 1 BOTTLE (59651-841-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","60429-960-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Golden State Medical Supply, Inc.","60429-960","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","10/06/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60429-960-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","60429-961-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Golden State Medical Supply, Inc.","60429-961","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","10/06/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60429-961-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","60429-962-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Golden State Medical Supply, Inc.","60429-962","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","10/06/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60429-962-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","60429-963-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Golden State Medical Supply, Inc.","60429-963","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","10/06/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60429-963-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","60760-863-30","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","ST. MARY'S MEDICAL PARK PHARMACY","60760-863","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/19/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60760-863-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","62332-745-31","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Inc.","62332-745","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-745-31)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","62332-745-91","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Inc.","62332-745","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-745-91)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","62332-746-91","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Inc.","62332-746","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-746-91)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","62332-746-31","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Inc.","62332-746","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-746-31)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","62332-747-31","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Inc.","62332-747","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-747-31)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","62332-747-91","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Inc.","62332-747","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-747-91)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","62332-748-31","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Inc.","62332-748","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-748-31)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","62332-748-91","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Alembic Pharmaceuticals Inc.","62332-748","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/08/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-748-91)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63187-302-90","1 mg/1","TABLET","ORAL","ANDA074673","Proficient Rx LP","63187-302","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/02/2016","N/A","ANDA","90 TABLET in 1 BOTTLE (63187-302-90)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63187-302-60","1 mg/1","TABLET","ORAL","ANDA074673","Proficient Rx LP","63187-302","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/02/2016","N/A","ANDA","60 TABLET in 1 BOTTLE (63187-302-60)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63187-302-30","1 mg/1","TABLET","ORAL","ANDA074673","Proficient Rx LP","63187-302","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/02/2016","N/A","ANDA","30 TABLET in 1 BOTTLE (63187-302-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-924-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-924","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-924-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-924-05","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-924","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-924-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-924-30","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-924","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-924-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-925-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-925","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-925-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-925-05","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-925","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-925-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-925-30","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-925","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-925-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-926-30","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-926","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-926-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-926","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-926-05","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-926","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-927-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-927","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-927-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-927-05","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-927","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-927-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63304-927-30","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Sun Pharmaceutical Industries, Inc","63304-927","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-927-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63629-1102-1","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Bryant Ranch Prepack","63629-1102","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1102-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63629-1103-1","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Bryant Ranch Prepack","63629-1103","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1103-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63629-8161-1","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Bryant Ranch Prepack","63629-8161","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/02/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8161-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63629-8203-1","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Bryant Ranch Prepack","63629-8203","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/29/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8203-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","63629-8203-2","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Bryant Ranch Prepack","63629-8203","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/24/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8203-2)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","67046-1433-3","1 mg/1","TABLET","ORAL","ANDA217293","Coupler LLC","67046-1433","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/08/2024","N/A","ANDA","30 TABLET in 1 BLISTER PACK (67046-1433-3)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine","67046-1655-3","2 mg/1","TABLET","ORAL","ANDA217293","Coupler LLC","67046-1655","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/28/2026","N/A","ANDA","30 TABLET in 1 BLISTER PACK (67046-1655-3)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine","70436-039-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA213428","Slate Run Pharmaceuticals, LLC","70436-039","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-039-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","70436-040-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA213428","Slate Run Pharmaceuticals, LLC","70436-040","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-040-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","70436-041-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA213428","Slate Run Pharmaceuticals, LLC","70436-041","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-041-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","70436-042-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA213428","Slate Run Pharmaceuticals, LLC","70436-042","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-042-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","70518-1369-0","1 mg/1","TABLET","ORAL","ANDA074145","REMEDYREPACK INC.","70518-1369","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/10/2018","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-1369-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine","70518-2771-1","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","REMEDYREPACK INC.","70518-2771","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","01/27/2025","N/A","ANDA","100 POUCH in 1 BOX (70518-2771-1)  / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-2771-2)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine","70518-2771-0","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","REMEDYREPACK INC.","70518-2771","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","06/08/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2771-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine","70518-3809-0","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","REMEDYREPACK INC.","70518-3809","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/29/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-3809-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","70518-4333-0","1 mg/1","TABLET","ORAL","ANDA217293","REMEDYREPACK INC.","70518-4333","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/25/2025","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-4333-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","70518-4488-0","2 mg/1","TABLET","ORAL","ANDA217293","REMEDYREPACK INC.","70518-4488","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/30/2025","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-4488-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","70518-4539-0","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219033","REMEDYREPACK INC.","70518-4539","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/23/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4539-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine","71205-944-00","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-944","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-944-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-944-30","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-944","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-944-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-944-55","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-944","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-944-55)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-944-60","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-944","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-944-60)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-944-90","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-944","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-944-90)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-945-90","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-945","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-945-90)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-945-60","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-945","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-945-60)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-945-55","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-945","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-945-55)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-945-30","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-945","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-945-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-945-00","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-945","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-945-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-946-30","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-946","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-946-55","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-946","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-55)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-946-60","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-946","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-60)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-946-90","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-946","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-90)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-946-00","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-946","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-947-55","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-947","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-947-55)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-947-00","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-947","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-947-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-947-30","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-947","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-947-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-947-60","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-947","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-947-60)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","71205-947-90","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","Proficient Rx LP","71205-947","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/19/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-947-90)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","71335-2379-1","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Bryant Ranch Prepack","71335-2379","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/27/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2379-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72162-1798-1","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Bryant Ranch Prepack","72162-1798","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1798-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72162-1799-1","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Bryant Ranch Prepack","72162-1799","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1799-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72162-1801-1","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205689","Bryant Ranch Prepack","72162-1801","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1801-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72266-255-55","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217638","Fosun Pharma USA, Inc","72266-255","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/28/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72266-255-55)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72266-256-55","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217638","Fosun Pharma USA, Inc","72266-256","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/28/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72266-256-55)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72266-257-55","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217638","Fosun Pharma USA, Inc","72266-257","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/28/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72266-257-55)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72266-258-55","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217638","Fosun Pharma USA, Inc","72266-258","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/28/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72266-258-55)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72888-123-05","1 mg/1","TABLET","ORAL","ANDA216762","Advagen Pharma Ltd","72888-123","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2021","N/A","ANDA","500 TABLET in 1 BOTTLE (72888-123-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72888-123-30","1 mg/1","TABLET","ORAL","ANDA216762","Advagen Pharma Ltd","72888-123","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2021","N/A","ANDA","30 TABLET in 1 BOTTLE (72888-123-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72888-123-01","1 mg/1","TABLET","ORAL","ANDA216762","Advagen Pharma Ltd","72888-123","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2021","N/A","ANDA","100 TABLET in 1 BOTTLE (72888-123-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72888-123-00","1 mg/1","TABLET","ORAL","ANDA216762","Advagen Pharma Ltd","72888-123","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2021","N/A","ANDA","1000 TABLET in 1 BOTTLE (72888-123-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72888-124-01","2 mg/1","TABLET","ORAL","ANDA216762","Advagen Pharma Ltd","72888-124","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2021","N/A","ANDA","100 TABLET in 1 BOTTLE (72888-124-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72888-124-00","2 mg/1","TABLET","ORAL","ANDA216762","Advagen Pharma Ltd","72888-124","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2021","N/A","ANDA","1000 TABLET in 1 BOTTLE (72888-124-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72888-124-30","2 mg/1","TABLET","ORAL","ANDA216762","Advagen Pharma Ltd","72888-124","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2021","N/A","ANDA","30 TABLET in 1 BOTTLE (72888-124-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine","72888-124-05","2 mg/1","TABLET","ORAL","ANDA216762","Advagen Pharma Ltd","72888-124","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2021","N/A","ANDA","500 TABLET in 1 BOTTLE (72888-124-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-224-05","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-224","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-224-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-224-30","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-224","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-224-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-224-00","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-224","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-224-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-224-01","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-224","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-224-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-225-30","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-225","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-225-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-225-00","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-225","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-225-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-225-01","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-225","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-225-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-225-05","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-225","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-225-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-226-01","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-226","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-226-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-226-00","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-226","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-226-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-226-05","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-226","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-226-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-226-30","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-226","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-226-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-227-00","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-227","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-227-00)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-227-05","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-227","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-227-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-227-30","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-227","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-227-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE","72888-227-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA219689","Advagen Pharma Limited","72888-227","GUANFACINE","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-227-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine ER","72189-469-30","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Direct_Rx","72189-469","Guanfacine ER","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/04/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-469-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine ER","72189-597-30","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217269","Direct_rx","72189-597","Guanfacine ER","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/03/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-597-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","50090-6493-0","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","A-S Medication Solutions","50090-6493","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/22/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6493-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","60505-3927-1","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Apotex Corp.","60505-3927","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/03/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3927-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","60505-3928-1","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Apotex Corp.","60505-3928","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/03/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3928-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","60505-3929-1","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Apotex Corp.","60505-3929","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/03/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3929-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","60505-3930-1","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Apotex Corp.","60505-3930","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/03/2018","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3930-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","70518-4266-0","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","REMEDYREPACK INC.","70518-4266","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/27/2025","N/A","ANDA","100 POUCH in 1 BOX (70518-4266-0)  / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-4266-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","71335-2852-1","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Bryant Ranch Prepack","71335-2852","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/30/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2852-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","71335-3005-1","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Bryant Ranch Prepack","71335-3005","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/05/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3005-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine extended-release","71335-3078-1","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Bryant Ranch Prepack","71335-3078","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/13/2026","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3078-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine extended-release","71335-9750-1","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Bryant Ranch Prepack","71335-9750","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/10/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9750-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine extended-release","71335-9750-2","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205430","Bryant Ranch Prepack","71335-9750","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/04/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9750-2)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine Hydrochloride","24979-198-01","1 mg/1","TABLET","ORAL","ANDA216399","TWi Pharmaceuticals, Inc.","24979-198","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/01/2022","N/A","ANDA","100 TABLET in 1 BOTTLE (24979-198-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","24979-199-01","2 mg/1","TABLET","ORAL","ANDA216399","TWi Pharmaceuticals, Inc.","24979-199","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/01/2022","N/A","ANDA","100 TABLET in 1 BOTTLE (24979-199-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","29300-458-01","1 mg/1","TABLET","ORAL","ANDA214689","Unichem Pharmaceuticals (USA), Inc.","29300-458","Guanfacine Hydrochloride","GUANFACINE","HUMAN PRESCRIPTION DRUG","04/05/2021","N/A","ANDA","100 TABLET in 1 BOTTLE (29300-458-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","29300-459-01","2 mg/1","TABLET","ORAL","ANDA214689","Unichem Pharmaceuticals (USA), Inc.","29300-459","Guanfacine Hydrochloride","GUANFACINE","HUMAN PRESCRIPTION DRUG","04/05/2021","N/A","ANDA","100 TABLET in 1 BOTTLE (29300-459-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","50090-6073-0","1 mg/1","TABLET","ORAL","ANDA075109","A-S Medication Solutions","50090-6073","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/14/2022","N/A","ANDA","30 TABLET in 1 BOTTLE (50090-6073-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","50268-374-15","2 mg/1","TABLET","ORAL","ANDA075109","AvPAK","50268-374","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/07/2017","N/A","ANDA","50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-374-15)  / 1 TABLET in 1 BLISTER PACK (50268-374-11)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2027"
"Guanfacine Hydrochloride","53746-711-01","1 mg/1","TABLET","ORAL","ANDA075109","Amneal Pharmaceuticals of New York LLC","53746-711","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2022","N/A","ANDA","100 TABLET in 1 BOTTLE (53746-711-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","53746-713-01","2 mg/1","TABLET","ORAL","ANDA075109","Amneal Pharmaceuticals of New York LLC","53746-713","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2022","N/A","ANDA","100 TABLET in 1 BOTTLE (53746-713-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","60687-710-21","1 mg/1","TABLET","ORAL","ANDA214689","American Health Packaging","60687-710","Guanfacine Hydrochloride","GUANFACINE","HUMAN PRESCRIPTION DRUG","11/09/2023","N/A","ANDA","30 BLISTER PACK in 1 CARTON (60687-710-21)  / 1 TABLET in 1 BLISTER PACK (60687-710-11)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE HYDROCHLORIDE","62135-727-90","1 mg/1","TABLET","ORAL","ANDA216399","Chartwell RX, LLC","62135-727","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/12/2023","N/A","ANDA","90 TABLET in 1 BOTTLE (62135-727-90)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"GUANFACINE HYDROCHLORIDE","62135-728-90","2 mg/1","TABLET","ORAL","ANDA216399","Chartwell RX, LLC","62135-728","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/12/2023","N/A","ANDA","90 TABLET in 1 BOTTLE (62135-728-90)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","65162-711-10","1 mg/1","TABLET","ORAL","ANDA075109","Amneal Pharmaceuticals LLC","65162-711","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/25/1998","N/A","ANDA","100 TABLET in 1 BOTTLE (65162-711-10)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","65162-711-03","1 mg/1","TABLET","ORAL","ANDA075109","Amneal Pharmaceuticals LLC","65162-711","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/25/1998","N/A","ANDA","30 TABLET in 1 BOTTLE (65162-711-03)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","65162-713-50","2 mg/1","TABLET","ORAL","ANDA075109","Amneal Pharmaceuticals LLC","65162-713","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/25/1998","N/A","ANDA","500 TABLET in 1 BOTTLE (65162-713-50)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","65162-713-10","2 mg/1","TABLET","ORAL","ANDA075109","Amneal Pharmaceuticals LLC","65162-713","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/25/1998","N/A","ANDA","100 TABLET in 1 BOTTLE (65162-713-10)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","65162-713-03","2 mg/1","TABLET","ORAL","ANDA075109","Amneal Pharmaceuticals LLC","65162-713","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/25/1998","N/A","ANDA","30 TABLET in 1 BOTTLE (65162-713-03)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","68094-065-62","1 mg/1","TABLET","ORAL","ANDA075109","Precision Dose, Inc.","68094-065","Guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2023","N/A","ANDA","3 BLISTER PACK in 1 CARTON (68094-065-62)  / 10 TABLET in 1 BLISTER PACK (68094-065-59)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","70518-3516-0","2 mg/1","TABLET","ORAL","ANDA214689","REMEDYREPACK INC.","70518-3516","Guanfacine Hydrochloride","GUANFACINE","HUMAN PRESCRIPTION DRUG","09/13/2022","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-3516-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","70700-301-30","1 mg/1","TABLET","ORAL","ANDA218326","XIROMED, LLC","70700-301","Guanfacine Hydrochloride","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/24/2024","N/A","ANDA","30 TABLET in 1 BOTTLE (70700-301-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","70700-301-01","1 mg/1","TABLET","ORAL","ANDA218326","XIROMED, LLC","70700-301","Guanfacine Hydrochloride","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/24/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (70700-301-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","70700-302-30","2 mg/1","TABLET","ORAL","ANDA218326","XIROMED, LLC","70700-302","Guanfacine Hydrochloride","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/24/2024","N/A","ANDA","30 TABLET in 1 BOTTLE (70700-302-30)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","70700-302-05","2 mg/1","TABLET","ORAL","ANDA218326","XIROMED, LLC","70700-302","Guanfacine Hydrochloride","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/24/2024","N/A","ANDA","500 TABLET in 1 BOTTLE (70700-302-05)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","70700-302-01","2 mg/1","TABLET","ORAL","ANDA218326","XIROMED, LLC","70700-302","Guanfacine Hydrochloride","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/24/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (70700-302-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","72603-268-01","1 mg/1","TABLET","ORAL","ANDA218326","NORTHSTAR RX LLC","72603-268","Guanfacine Hydrochloride","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/15/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (72603-268-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Guanfacine Hydrochloride","72603-269-01","2 mg/1","TABLET","ORAL","ANDA218326","NORTHSTAR RX LLC","72603-269","Guanfacine Hydrochloride","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/15/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (72603-269-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Intuniv","54092-513-02","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022037","Takeda Pharmaceuticals America, Inc.","54092-513","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/02/2009","N/A","NDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-513-02)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Intuniv","54092-515-02","2 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022037","Takeda Pharmaceuticals America, Inc.","54092-515","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/02/2009","N/A","NDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-515-02)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Intuniv","54092-517-02","3 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022037","Takeda Pharmaceuticals America, Inc.","54092-517","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/02/2009","N/A","NDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-517-02)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"
"Intuniv","54092-519-02","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022037","Takeda Pharmaceuticals America, Inc.","54092-519","guanfacine","GUANFACINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/02/2009","N/A","NDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-519-02)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2026"